Corporate DisclosureRENATA
RENATA Corporate Disclosure — 18 January 2018
Announcement summary
- What happened
- RENATA published a corporate disclosure on 18 January 2018. Read the full announcement for details.
- Company
- Renata PLC
- Announcement published
Original announcement
The Company has informed their following recent developments: 1. Two factories, viz., the Potent Product Facility at Mirpur and the General Facility at Rajendrapur have been approved by the Medicines and Healthcare products Agency (MHRA) of the UK. 2. Renata has received registration for two products in the UK. The sales of Hydrocortisone 10 mg and 20 mg tablets shall begin in February to be followed by Colcichine 500 mg tablets. (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acef05a6b00004005d95f
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from RENATA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.